Monitor FDA drug approval timelines and safety review processes over next 6 months for changes in scientific rigor or political interference in pharmaceutical regulation.
Single personnel action at FDA scores moderate on institutional capture (4/5) but lacks the systemic scope or irreversibility of mass purges. However, B-score is elevated (51) due to high intentionality markers: dropped during a week with multiple higher-A events (diplomatic purge, $1.776B political fund, DACA delays), fits established pattern of agency loyalty enforcement, and generates media attention disproportionate to governance impact of one firing. Limited sourcing (single Hawaii Tribune article) reduces confidence.